← Leaderboards
Kepeng Wang
University Of Connecticut Sch Of Med/Dnt
$1,841,987
Attributed
$1,841,987
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $375.1K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,841,987 · 1
By mechanism
R01$1,841,987 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Connecticut Sch Of Med/Dnt
Same institution · by research overlap
- Wolfgang Peti$11,584,455
- Masako Nakanishi$1,002,395
- Nilanjana Maulik$9,958,854
Others in their field
Other Emerging Leaders on “Colonic Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Lynn Briscoe · Leidos Biomedical Research, Inc.$26,195,254
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Leonard Freedmand · Leidos Biomedical Research, Inc.$9,965,931
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
- Rory Wolfe · Hennepin Healthcare Research Institute$6,860,202
Research focus
Colonic NeoplasmsColorectal Cancer TreatmentAdjuvantColonColorectal CancerAntibodiesAnticancer ActivityAnti-Inflammatory AgentsAblationChemokineColon TumorigenesisAdaptive ImmunityB-LymphocytesCancer ImmunotherapyCancer InitiationCancer PreventionCcr6 GeneCd8b1 GeneAutoimmunityAdoptive TransferBacterial InfectionsCellsAffectColorectal Neoplasms
Grant awards (5)
Control of regulatory T cells by IL-17 in colorectal cancer$375,150
R01 · FY2025 · CA · contact PI
Control of regulatory T cells by IL-17 in colorectal cancer$356,393
R01 · FY2024 · CA · contact PI
Control of regulatory T cells by IL-17 in colorectal cancer$367,647
R01 · FY2023 · CA · contact PI
Control of regulatory T cells by IL-17 in colorectal cancer$367,647
R01 · FY2022 · CA · contact PI
Control of regulatory T cells by IL-17 in colorectal cancer$375,150
R01 · FY2021 · CA · contact PI